[Clinical effectiveness and tolerance of acarbose in the treatment of insulin-dependent diabetic patients (type I)].

Abstract

BACKGROUND Acarbose is a reversible inhibitor of the intestinal alpha-glucosidases, the oral administration of which delays or diminishes the postprandial increase of glucose and insulin. METHODS A multicentric double-blind clinical trial (11 centers), controlled versus placebo, crossed and randomized, was carried out with 137 insulin-dependent diabetic… (More)

Topics

Cite this paper

@article{EscobarJimnez1993ClinicalEA, title={[Clinical effectiveness and tolerance of acarbose in the treatment of insulin-dependent diabetic patients (type I)].}, author={Fern{\'a}ndo Escobar-Jim{\'e}nez and Alberto D De Leiva and Fabien Pinon and Joan Soler and Javier T{\'e}bar and M. A. Sancho and Jos{\'e} Luis Herrera-Pombo and Lu{\'i}s Felipe Pallardo and Julio Vazquez and Hermenegildo de la Calle}, journal={Medicina clinica}, year={1993}, volume={100 13}, pages={488-91} }